CLINICAL_TRIALS
trial_result
· 2021-07-14
Clinical Trial Update: Elixir Medical Evaluation of the DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System - Cx Registry [NA]
Summary
Clinical trial update for the DESolve Novolimus eluting bioresorbable scaffold system in coronary artery disease has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Elixir Medical Corporation | Conditions: Coronary Artery Disease | NA | Status: COMPLETED | Results posted: 2021-07-14